Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial

N. Ruperto,Daniel J. Lovell,Pierre Quartier,Angelo Ravelli,Mahinda Karunaratne,Jasmina Kalabic,Anabela Cardoso,Alberto Martini,Gerd Horneff

Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial

2014

N. Ruperto
Daniel J. Lovell
Pierre Quartier
Angelo Ravelli
Mahinda Karunaratne
Jasmina Kalabic
Anabela Cardoso
Alberto Martini
Gerd Horneff

The Juvenile Arthritis Disease Activity Score (JADAS) 1 is becoming widely accepted in juvenile idiopathic arthritis (JIA) for defining a treat to target strategy.

Keywords:

Phases of clinical research
Arthritis
Rheumatology
Physical therapy
Adalimumab
Juvenile Arthritis Disease Activity Score
Juvenile
Disease
Medicine
Internal medicine
minimal disease
treat to target

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations